Skip to main content
Caplight Logo









Vivtex

Vivtex

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://vivtex.com/

Last Round

Accelerator

May 9, 2024

Total Funding Raised

$1.8M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Vivtex is a biotechnology company that operates a healthcare platform for drug development using robotic technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

oral biologicsdrug delivery platforminjectable to oraloral peptidesGI-ORIS platformdrug co-developmentrobotic screeninghigh-throughput screeningHTSoral absorption predictiondrug formulationGastrointestinal Organ Robotic Interface Systemex vivo screeningbiologic therapeuticsdrug development royalties

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivtex Comparables

Compare Vivtex with similar companies based on industry and business-model similarity.

Vivtex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
i2O Therapeutics
87%
Cyprumed GmbH
80%
Biograil
79%

Vivtex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 9, 2024
Convertible DebtAug 19, 2022

Key People

Founding team and executive leadership

Thomas von Erlach

Co-Founder And CEO

Founding Team

Vivtex Investors

Notable investors and investment history

Vivtex investors
InvestorRounds
The Elizabeth Elting Venture FundAccelerator
Endless Frontier LabsAccelerator
Portal InnovationsConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2026

    Grew 40% QoQ, from 20 to 28 employees.

  • Jul 19, 2026

    Grew 20% QoQ, from 20 to 24 employees.

Vivtex Filings

Explore SEC and related filing metadata, where available.

Vivtex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vivtex's valuation, stock price, and market status.

Is Vivtex a public or private company?

Vivtex is a private company.

What is the current stock price of Vivtex?

Vivtex is a private company with no public stock price. No recent secondary market data is available.

How much is Vivtex worth (valuation)?

Valuation information for Vivtex is not publicly available.

Can I buy Vivtex stock?

Vivtex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vivtex's last funding round?

Vivtex's most recent funding round was Accelerator on May 9, 2024.

Who are the main investors in Vivtex?

Key investors in Vivtex include The Elizabeth Elting Venture Fund, Endless Frontier Labs, Portal Innovations.

Will Vivtex IPO soon?

No public IPO plans have been announced for Vivtex.

How can I track Vivtex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vivtex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range25
Year Founded2018
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?